NCT00963872 · OUTCOME

Relapse of Disease

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: Day 720

What was measured

Patients who developed disease relapse after transplantation.

Analysis population: Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.

Groups in this outcome

Complement Fragment 3A - Small Cell Dose

Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.

Complement Fragment A - Larger Cell Dose

Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Complement Fragment 3A - Small Cell Dose	24
Complement Fragment A - Larger Cell Dose	5

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Complement Fragment 3A - Small Cell Dose	11	Not reported	Not reported	Not reported	Not reported
Complement Fragment A - Larger Cell Dose	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
11
group Id
OG001
value
1

denoms

counts
group Id
OG000
value
24
group Id
OG001
value
5
units
Participants

description

Patients who developed disease relapse after transplantation.

groups

description
Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.
id
OG000
title
Complement Fragment 3A - Small Cell Dose
description
Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.
id
OG001
title
Complement Fragment A - Larger Cell Dose

param Type

NUMBER

population Description

Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.

reporting Status

POSTED

time Frame

Day 720

title

Relapse of Disease

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice